相关实验视频

Updated: Sep 11, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

设计,合成,生物评估和计算研究新型1,4-Diketopiperazines作为GABA激动剂的研究

Mostafa Abd El-Mohsen Anwar¹, Eman R Mohammed², Samir M El Moghazy²

¹Pharmaceutical Chemistry Department, Collage of Pharmaceutical Science and Drug Manufacturing, Misr University for Science and Technology, Giza, Egypt.

Drug development research

|August 11, 2025

概括

新型环素化合物表现出强大的抗发作活性,没有神经毒性. 化合物8c是最有效的,增强GABA水平并表现出神经保护性质,表明治疗的潜力.

科学领域:

药用化学医学化学
神经药理学神经药理学
药物发现药物发现药物发现

背景情况:

仍然是一个重要的神经系统疾病,有未满足的治疗需求.
开发具有更好的疗效和安全性特征的新型抗药物至关重要.
环素衍生物是探索新治疗剂的有希望的支架.

研究的目的:

设计,合成和评估一系列新型的1,1-非替代环素化合物,用于抗作用.
研究最有效化合物的神经保护作用和潜在机制.
评估这些化合物的潜力,作为未来抗药物开发的途径.

主要方法:

合成1,1-非替代的环素衍生物 (化合物7a-e,8a-e,9a-e).
在体内使用最大电击发作 (MES) 和乙 (PTZ) 诱导的发作模型进行抗性查.
神经毒性评估,定量抗活性测试,Nrf2-ARE通路分析,氧化应激标志物评估和脑部组织病理学检查.
对GABA水平和in silico研究的神经化学分析,包括对接和药物动力学预测.

主要成果:

化合物7c,8c,8d和9a在初步查中表现出显著的抗活性,没有观察到神经毒性.
化合物8c在第二阶段测试中表现出与巴比特相比更强的功效.
组织病理学和神经化学分析证实了神经保护性质,并显著改善了PTZ诱导的GABA水平的降低,表明增强了GABAergic神经传递.
在的研究表明,这些化合物具有良好的口服生物可用性和血脑屏障透性.

结论:

这种新型的1,1-非替代环素衍生物具有显著的抗和神经保护潜力.
化合物8c被确定为作为抗药物进一步开发的非常有前途的领先候选人.
观察到GABAergic神经递质的增强和有利的药物动力学概况支持它们的治疗潜力.

关键词:

第111章这是一件好事 4-狄基托皮帕拉津-4-狄基托皮帕拉津.ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME ADME 在 GABA-AT 组合中,GABA-AT 组合是抗药是一种抗药.停靠研究对接研究.神经保护神经保护氧化应激是一种氧化应激.

更多相关视频

Preparation of Stable Bicyclic Aziridinium Ions and Their Ring-Opening for the Synthesis of Azaheterocycles

Preparation of Stable Bicyclic Aziridinium Ions and Their Ring-Opening for the Synthesis of Azaheterocycles

Published on: August 22, 2018

Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets

Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets

Published on: March 12, 2019

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...

G Protein-coupled Receptors

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...

Antiepileptic Drugs: GABAergic Pathway Potentiators

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

Drug-Receptor Interaction: Agonist

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...